RecalledThisWeek Search
Medium risk Drugs & MedicationsClass II

Lupin Liraglutide Injection Recall

Liraglutide Injection, 18 mg/3 mL (6 mg/mL), Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Naples, FL 34108, Manufactured by: Lupi

Updated April 24, 2026

Lupin Pharmaceuticals has recalled Liraglutide Injection 18 mg/3 mL due to the presence of a white thread-like structure found in some cartridges. Using a contaminated pen may pose a safety risk.

Is the Lupin Pharmaceuticals Inc. recalled? Yes. This product was recalled by FDA on April 24, 2026. Details below.

What is recalled

Liraglutide Injection, 18 mg/3 mL (6 mg/mL), prescription-only, manufactured by Lupin Limited in Nagpur, India for Lupin Pharmaceuticals, Inc., Naples, FL. Affected products: 2-pen packs (NDC 70748-346-02) and 3-pen packs (NDC 70748-346-03).

Am I affected

You're affected if you have a Liraglutide Injection pen from Lupin Pharmaceuticals with NDC 70748-346-02 (2-pen pack) or NDC 70748-346-03 (3-pen pack). Check the package label for these NDC numbers.

What to do right now

Stop using this medication immediately. Contact your prescriber or pharmacist right away before taking your next dose to discuss whether to return the product or obtain a replacement.

The hazard

Presence of particulate matter: a white thread-like structure in the cartridge

Brands affected

Lupin Pharmaceuticals Inc.
Source
FDA
Category
Drugs & Medications
Recall ID
fda-D-0541-2026
Classification
Class II
Recalled
April 24, 2026
Read the official notice

Get free recall alerts

New Drugs & Medications recalls, the moment they post.

Free forever. Unsubscribe anytime. We never sell your data.

More Drugs & Medications recalls